Tag: CV Sciences
CV Sciences Developing CBD-based Pharma for Nicotine Addiction
San Diego, CA—CV Sciences is working toward its goal of developing and commercializing a cannabidiol- (CBD)-based pharmaceutical to treat nicotine addiction in smokeless tobacco...
Stress and Sleep Gummies
CV Sciences has launched PlusCBD Calm and Sleep: two gummies that support healthy stress responses and sleep cycles. Each gummy contains 10mg of CBD...
CV Sciences Q1 Results Show Increased Distribution
San Diego, CA—CV Sciences has announced financial results for Q1 2021, the period ended March 31, 2021. Results include a much broader distribution, according...
CV Sciences, Alkemist Partner on Cannabis Testing Program
San Diego, CA—CV Sciences has announced an ongoing partnership with Alkemist Labs in a press release. The two will collaborate with the National Institute...
Fortify and Optimize Your Immune Response
Click here to listen.
Your body comes with its own built in defense system that is always on surveillance to protect you from immune...
Pet CBD Line
CV Sciences has launched PlusCBD Pet, a full line of hemp extracts formulated exclusively for dogs and cats. PlusCBD Pet is available in 250mg...
CV Sciences Announces Q3 Results
San Diego, CA—CV Sciences has announced financial results for the third quarter 2020 ended September 30. A press release notes a decrease in sales...
Immunity Supplement
CV Sciences has launched CV Defense, the second product announced under its new Immunity product line, CV Acute. CV Defense provides daily support for...
CV Sciences Contributes to First Special Issue on Cannabinoids
San Diego, CA—CV Sciences has published four papers in the Journal of Dietary Supplements’ first special issue on cannabinoids, according to a press release.
Douglas...
CBD Product Line
CV Sciences has announced the launch of its new Happy Lane CBD product line. Happy Lane non-GMO, hemp derived CBD products are manufactured with...
